Michael Anglesio
Michael Anglesio
Assistant Professor, Department of Obstetrics & Gynaecology, University of British Columbia
Verified email at ubc.ca - Homepage
Cited by
Cited by
ARID1A mutations in endometriosis-associated ovarian carcinomas
KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ...
New England Journal of Medicine 363 (16), 1532-1543, 2010
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers
A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ...
New England Journal of Medicine 366 (3), 234-242, 2012
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ...
The Journal of pathology 231 (1), 21-34, 2013
Cancer-associated mutations in endometriosis without cancer
MS Anglesio, N Papadopoulos, A Ayhan, TM Nazeran, M Noë, ...
New England Journal of Medicine 376 (19), 1835-1848, 2017
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ...
The lancet oncology 14 (9), 853-862, 2013
Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer
A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ...
Cancer 123 (5), 802-813, 2017
Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species
V Evdokimova, P Ruzanov, MS Anglesio, AV Sorokin, LP Ovchinnikov, ...
Molecular and cellular biology 26 (1), 277-292, 2006
Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010
MS Anglesio, MS Carey, M Köbel, H MacKay, DG Huntsman
Gynecologic oncology 121 (2), 407-415, 2011
Type-specific cell line models for type-specific ovarian cancer research
MS Anglesio, KC Wiegand, N Melnyk, C Chow, C Salamanca, ...
PloS one 8 (9), e72162, 2013
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer
MS Anglesio, J George, H Kulbe, M Friedlander, D Rischin, C Lemech, ...
Clinical cancer research 17 (8), 2538-2548, 2011
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
MS Anglesio, S Kommoss, MC Tolcher, B Clarke, L Galletta, H Porter, ...
The Journal of pathology 229 (1), 111-120, 2013
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
Ĺ Helland, MS Anglesio, J George, PA Cowin, CN Johnstone, CM House, ...
PloS one 6 (4), e18064, 2011
Interfaces of malignant and immunologic clonal dynamics in ovarian cancer
AW Zhang, A McPherson, K Milne, DR Kroeger, PT Hamilton, A Miranda, ...
Cell 173 (7), 1755-1769. e22, 2018
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
YK Wang, A Bashashati, MS Anglesio, DR Cochrane, DS Grewal, G Ha, ...
Nature genetics 49 (6), 856-865, 2017
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers
L Zhang, MS Anglesio, M O'Sullivan, F Zhang, G Yang, R Sarao, ...
Nature medicine 13 (9), 1060-1069, 2007
Subtype‐specific mutation of PPP2R1A in endometrial and ovarian carcinomas
MK McConechy, MS Anglesio, SE Kalloger, W Yang, J Senz, C Chow, ...
The Journal of pathology 223 (5), 567-573, 2011
Cancer‐associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse‐strand expression bias to predominantly mature 3p strands …
MS Anglesio, Y Wang, W Yang, J Senz, A Wan, A Heravi‐Moussavi, ...
The Journal of pathology 229 (3), 400-409, 2013
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
SM Hunter, MS Anglesio, GL Ryland, R Sharma, YE Chiew, SM Rowley, ...
Oncotarget 6 (35), 37663, 2015
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors
MS Anglesio, JM Arnold, J George, AV Tinker, R Tothill, N Waddell, ...
Molecular cancer research 6 (11), 1678-1690, 2008
Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney
MS Anglesio, V Evdokimova, N Melnyk, L Zhang, CV Fernandez, ...
Human molecular genetics 13 (18), 2061-2074, 2004
The system can't perform the operation now. Try again later.
Articles 1–20